KemPharm
4,172
$0.26339876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.2633
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0573 (+27.82%) Today
$0.00 (0.00%) As of 4:51 PM EDT after-hours
Why Robinhood?
You can watch KemPharm and buy or sell other stocks, options, ETFs, and crypto commission-free!
About KMPH
KemPharm, Inc. Common Stock, also called KemPharm, is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. Read More It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.
Employees
22
Headquarters
Celebration, Florida
Founded
2006
Market Cap
17.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.15M
High Today
$0.2801
Low Today
$0.2405
Open Price
$0.2723
Volume
1.34M
52 Week High
$1.79
52 Week Low
$0.121